Safety and effectiveness of CATCH+ as a first-line device for revascularization in the treatment of acute ischemic stroke - 04/02/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | The aim of the present study was to evaluate the safety and effectiveness of the CE certified CATCH+ stent retriever. |
• | Evaluation of the CATCH+ device in a real-world setting presenting the largest number of clinical patients treated with this device. |
• | The device is safe for usage as a first line device in intracranial thrombectomy. |
• | Similar performance characteristics to the Solitaire FR device with comparable clinical and angiographic results. |
• | Stroke is the most common cause of permanent disability, the second most common cause of dementia, and the fourth most common cause of death in the Western world. |
Abstract |
Purpose |
Mechanical thrombectomy devices and stent retrievers have recently been advocated for use as first-line therapy in acute ischemic stroke. Here we evaluate the safety and effectiveness of the CATCH+ stent retriever as a percutaneous thrombectomy device.
Methods |
A retrospective analysis was performed on 101 consecutive patients who presented with anterior or posterior intracranial vessel occlusion and were treated with the CATCH+ intracranial system, either alone or in combination with intravenous tissue plasminogen activator, at a single treatment center. The primary outcome measure was successful post-procedural reperfusion as classified by the mTICI score. Secondary endpoints included mortality rate, incidence of adverse events, and functional outcomes evaluated at discharge using the mRS score.
Results |
Sixty-nine (68.3%) patients received thrombolysis prior to mechanical thrombectomy. Successful reperfusion (mTICI≥2b) was achieved in 73.3% of patients at the end of the procedure, and good functional outcomes (mRS≤2) were observed in 32.7% of patients at discharge. Three patients developed asymptomatic subarachnoid hemorrhage, two developed asymptomatic dissections of the internal carotid artery, and one patient developed a symptomatic intracranial hemorrhage. Seventeen patients died (mortality rate 16.8%).
Conclusions |
The CATCH+ device is a safe and effective mechanical thrombectomy device for the first-line treatment of acute ischemic stroke.
Le texte complet de cet article est disponible en PDF.Keywords : Ischemic stroke, Stent retriever, Mechanical thrombectomy, CATCH+
Plan
Vol 48 - N° 1
P. 5-9 - février 2021 Retour au numéro
Article précédent
- Interventional neuroradiology in France, quo vadis?
- Grégoire Boulouis, Jérôme Berge, Hubert Desal, Jean Pierre Pruvo, Emmanuel Touzé, François Cotton, SFNR
- Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome
- Lukas Andereggen, Jan Gralla, Gerhard Schroth, Pasquale Mordasini, Robert H. Andres, Hans Rudolf Widmer, Markus M. Luedi, Frauke Kellner, Jürgen Beck, Luigi Mariani, Christoph Ozdoba, Emanuel Christ
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?